SOFT TISSUE NEOPLASM

SOFT TISSUE NEOPLASM was reported 132 times

SOFT TISSUE NEOPLASM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] 1 0.0017
1 Interferon alfa-2b [EPC] 1 0.0005
2 Bispecific CD20-directed CD3 T Cell Engager [EPC] 1 0.0002
3 Neonatal Fc Receptor Blocker [EPC] 1 0.0002
4 alpha-Glucosidase Inhibitor [EPC] 1 0.0002
5 Estrogen Receptor Antagonist [EPC] 7 0.0002
6 Autologous Cellular Immunotherapy [EPC] 1 0.0002
7 Cannabinoid [EPC] 1 0.0001
8 Aromatase Inhibitor [EPC] 10 0.0001
9 Potassium-sparing Diuretic [EPC] 1 0.0001
10 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
11 Microtubule Inhibitor [EPC] 10 0.0001
12 Interleukin-1 Receptor Antagonist [EPC] 1 0.0001
13 Alkylating Drug [EPC] 14 0.0001
14 Azole Antifungal [EPC] 9 0.0001
15 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
16 Selective T Cell Costimulation Modulator [EPC] 7 0.0001
17 Nitrate Vasodilator [EPC] 3 0.0000
18 Parathyroid Hormone-Related Peptide Analog [EPC] 1 0.0000
19 Purine Antimetabolite [EPC] 3 0.0000
20 Folate Analog Metabolic Inhibitor [EPC] 12 0.0000
21 Parathyroid Hormone Analog [EPC] 3 0.0000
22 Topoisomerase Inhibitor [EPC] 2 0.0000
23 Kinase Inhibitor [EPC] 14 0.0000
24 Calcineurin Inhibitor Immunosuppressant [EPC] 3 0.0000
25 CD20-directed Cytolytic Antibody [EPC] 7 0.0000
26 Interleukin-6 Receptor Antagonist [EPC] 3 0.0000
27 Calcium [EPC] 3 0.0000
28 5-alpha Reductase Inhibitor [EPC] 2 0.0000
29 Corticosteroid [EPC] 25 0.0000
30 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
31 Proteasome Inhibitor [EPC] 2 0.0000
32 Vitamin C [EPC] 7 0.0000
33 Aromatic Amino Acid [EPC] 1 0.0000
34 Vitamin D [EPC] 5 0.0000
35 BCL-2 Inhibitor [EPC] 1 0.0000
36 Vitamin B12 [EPC] 5 0.0000
37 RANK Ligand Inhibitor [EPC] 3 0.0000
38 Opioid Agonist [EPC] 4 0.0000
39 Angiotensin Converting Enzyme Inhibitor [EPC] 2 0.0000
40 Nucleoside Metabolic Inhibitor [EPC] 4 0.0000
41 Expectorant [EPC] 3 0.0000
42 Thiazide Diuretic [EPC] 3 0.0000
43 HER2/neu Receptor Antagonist [EPC] 1 0.0000
44 Angiotensin 2 Receptor Blocker [EPC] 4 0.0000
45 Catecholamine [EPC] 1 0.0000
46 Nucleoside Analog Antiviral [EPC] 1 0.0000
47 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
48 Integrin Receptor Antagonist [EPC] 1 0.0000
49 Thalidomide Analog [EPC] 6 0.0000
50 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
51 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
52 Vascular Endothelial Growth Factor Inhibitor [EPC] 2 0.0000
53 HMG-CoA Reductase Inhibitor [EPC] 4 0.0000
54 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
55 Antirheumatic Agent [EPC] 1 0.0000
56 Platelet Aggregation Inhibitor [EPC] 5 0.0000
57 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
58 Fluoroquinolone Antibacterial [EPC] 1 0.0000
59 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
60 alpha-Adrenergic Blocker [EPC] 1 0.0000
61 Tumor Necrosis Factor Blocker [EPC] 7 0.0000
62 Proton Pump Inhibitor [EPC] 4 0.0000
63 Insulin Analog [EPC] 3 0.0000
64 Loop Diuretic [EPC] 3 0.0000
65 beta-Adrenergic Blocker [EPC] 2 0.0000
66 Aldosterone Antagonist [EPC] 1 0.0000
67 Janus Kinase Inhibitor [EPC] 1 0.0000
68 Nonsteroidal Anti-inflammatory Drug [EPC] 8 0.0000
69 Estrogen [EPC] 1 0.0000
70 Interferon beta [EPC] 1 0.0000
71 Platinum-based Drug [EPC] 1 0.0000
72 Factor Xa Inhibitor [EPC] 1 0.0000
73 Osmotic Laxative [EPC] 1 0.0000
74 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
75 Benzodiazepine [EPC] 2 0.0000
76 GLP-1 Receptor Agonist [EPC] 1 0.0000